SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

FEFE CRYPTO is trending as its passionate community champions the "three frogs trilogy" narrative, positioning it as the spiritual successor to $PEPE and $HOPPY within the Matt Furie meme universe. This resilient, community-owned token is seen by its holders as an incredibly undervalued asset with significant 1000x potential within the broader frog memecoin meta.

Capri Holdings Ltd. operates as a global fashion luxury group. It engages in the design and distribution of sportswear, accessories, footwear and apparel of branded women's apparel, and accessories and men's apparel. The firm operates through the following segments: Versace, Jimmy Choo, and Michael Kors. The Versace segment sells Versace luxury ready-to-wear, accessories, footwear, and home furnishings through directly operated Versace boutiques. The Jimmy Choo segment sells Jimmy Choo luxury goods to end clients through directly operated Jimmy Choo stores. The Michael Kors segment sells Michael Kors products through four primary Michael Kors retail store formats such as Collection, Lifestyle, outlet stores, and e-commerce. The company was founded by Michael David Kors on December 13, 2002 and is headquartered in London, the United Kingdom.

Capri Holdings Ltd

Capri Holdings is gaining significant attention following a better-than-expected earnings report and multiple analyst upgrades, as the community discusses its strategic pivot and strengthened financial outlook post-Versace divestiture.

What Is Pi Network? Pi Network is a social cryptocurrency, developer platform, and ecosystem designed for widespread accessibility and real-world utility. It enables users to mine and transact Pi using a mobile-friendly interface while supporting applications built within its blockchain ecosystem.  Supply Model and Mining Mechanism The Maximum Supply of Pi is 100 billion tokens. The Maximum Supply is comprised of the following: 65 Billion tokens (or 65%) are allocated for all community mining rewards; 10 billion (10%) are allocated for foundation reserves; 5 billion (5%) are allocated for liquidity purposes; and 20 billion (20%) are allocated for the Core Team. Each allocation mentioned above tracks the community Migrated Mining Rewards issuance pace, so the proportions of each allocation in the total supply remains the same at any given time.   The Effective Total Supply of Pi—the total Pi supply at the current time—allocates Pi proportionally the same as the Maximum Supply. Since every allocation tracks the Migrated Mining Rewards of the community, the Effective Total Supply can be calculated by dividing the current Migrated Mining Rewards of Pi on the Mainnet blockchain by 65%. The other allocations within the Effective Total Supply can then be calculated based on the same proportions as the Maximum Supply, e.g. at most 10% of the Effective Total Supply is available in the foundation reserve, 5% of the Effective Total Supply is available for liquidity purposes, and 20% of the Effective Total Supply is available for the Core Team. This remains true despite the fact that all tokens were minted at the genesis as technically required by the blockchain protocol.  Circulating Supply includes all Migrated Mining Rewards and all tokens that entered circulation from other buckets of the allocations, which at its maximum could be summed up to equal the Effective Total Supply.   Pi’s mining rewards are distributed based on an issuance formula that follows a declining exponential model defined in the Pi whitepaper. Users can increase the amount of mining rewards they receive based on their individual contributions to the network, like Security Circles, using utility-based Pi apps, running Nodes, etc. For each month, the amount of Pi to be distributed as mobile balance is capped and determined by the model, regardless of how many people or how many types of mining rewards there are during the month. The capping is achieved by the design of a system-wide base mining rate, and each type of mining rewards to each individual are just a multiplier of this base mining rate. As the monthly supplies always diminish, the base mining rate generally decreases over time.   Fewer Pi may also be issued because the real Pi issuance on the blockchain depends on Pioneers passing KYC and completing all steps required for migration to the Mainnet. Despite all efforts to facilitate and remind Pioneers to complete those required steps, there are always dropoffs along the way, resulting in less than all outstanding mobile balances to be issued on the blockchain. Because of this mechanism, the community issued amount (Migrated Mining Rewards) on the blockchain will likely be closer and closer to a line lower than the 65 billion. This is thus the reason for the variable Effective Total Supply which incorporates this effect. Effective Total Supply results from all Migrated Mining Rewards divided by 65%, as opposed to the Maximum Supply of 100 billion.  Ecosystem and Adoption Pi Network has built an integrated ecosystem that facilitates real-world transactions and decentralized applications. Pi can be used as a medium of exchange for goods and services, including online commerce and local brick-and-mortar businesses.  Users can engage with Core Team and community-built apps in the Pi ecosystem through the Pi Browser, where integrated features like the Pi Wallet provide a seamless experience. Events like PiFest 2024 showcased Pi’s growing adoption, with over 27,000 active sellers and 28,000 test merchants across 160 countries.  Who Are the Founders of Pi Network? Pi Network was founded by Dr. Nicolas Kokkalis and Dr. Chengdiao Fan, both of whom have PhDs from Stanford University and a passion for improving human lives through technology.  Dr. Nicolas Kokkalis is a Stanford PhD in EE and postdoc in CS with research on distributed systems and human-computer interaction. His work focuses on combining distributed systems and human computer interaction to bring cryptocurrency to everyday people. As a strong and long-term believer of the technical, financial and social potential of cryptocurrencies, he is determined to move them beyond their current limitations and is committed to bringing the power of blockchain to more people.  Dr. Chengdiao Fan holds a Stanford PhD in Anthropological Sciences, harnessing social computing to unlock human potential on a global scale. Chengdiao is building Pi Network to mobilize individuals all over the world to participate and be rewarded for their contributions, and establish an inclusive ecosystem for global citizens to unleash and capture their own agency, and in turn create utilities and productions for society and the world.  Compliance and Identity Verification Pi Network follows a one-account-per-person policy through its Know Your Customer (KYC) solution. This system combines machine automation and human verification to authenticate user identities while preserving privacy.  The KYC process emphasizes real individuals, combats fraudulent activities and enables fair participation in the mining process of the network. Pi’s identity verification approach balances scalability, security, and accessibility, allowing millions of users worldwide to validate their accounts while maintaining regulatory compliance.

Pi Network

The community is actively debating Pi Network's prolonged mainnet launch, with widespread frustration over unresolved KYC and coin migration issues, compounded by its absence from major crypto exchanges. Despite some pioneers maintaining long-term bullish sentiment, many users express skepticism, questioning its real-world utility and likening the project to an ad revenue scheme.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is actively discussed after ending acquisition talks for Revolution Medicines, which frees capital for its urgent strategy to bolster its oncology pipeline and mitigate the looming Keytruda patent cliff. Positive updates for its RSV vaccine and partnered cancer immunotherapy also draw investor attention.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is trending as cybersecurity stocks respond to the emergence of new AI code security tools, fueling community debate over potential disruption versus the significant new growth opportunity for Okta in securing AI agents and digital identities.

SSgA Active Trust - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The Financial Select Sector SPDR Fund (XLF) is trending due to widespread technical weakness and a prevailing bearish sentiment, with community discussion highlighting a potential major breakdown and eyeing key support levels. Concerns over broader economic health, including consumer delinquencies, and policy discussions like potential credit card rate caps, are contributing to a cautious outlook despite mixed bank earnings reports.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is actively discussed as investors anticipate its upcoming earnings report, with community sentiment balancing strong long-term growth expectations from yield enhancements and pipeline advancements against recent concerns regarding an FDA alert on specific product lots.

Bombardier Cl B Sv

Bombardier is a major talking point as the market reacts to potential US tariff threats against Canadian goods, though many in the community believe the company's business jets may be exempt under trade agreements or can navigate any new duties. This uncertainty contrasts with strong underlying financials and future growth prospects driven by new aircraft orders, defense opportunities, and consistent delivery performance, fueling investor frustration over recent share price volatility.

General Mills, Inc. engages in the manufacture and marketing of branded consumer foods sold through retail stores. Its product categories include snacks, ready-to-eat cereal, convenient meals, pet food, refrigerated and frozen dough, baking mixes and ingredients, yogurt, and ice cream. It operates through the following segments: North America Retail, International, North America Pet, and North America Foodservice. The North America Retail segment includes grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, convenience stores, and e-commerce grocery providers. The International segment refers to the retail and foodservice businesses outside of the US and Canada. The North America Pet segment includes pet food products sold in national pet superstore chains, e-commerce retailers, grocery stores, regional pet store chains, mass merchandisers, and veterinary clinics and hospitals. The North America Foodservice segment offers ready-to-eat cereals, snacks, refrigerated yogurt, frozen meals, unbaked and fully baked frozen dough products, baking mixes, and bakery flour. The company was founded by Cadwallader C. Washburn on June 20, 1928 and is headquartered in Minneapolis, MN.

General Mills, Inc.

General Mills is trending following a revised fiscal 2026 outlook citing weak consumer demand and tariff impacts, leading to a notable stock decline; however, the community is actively discussing its defensive qualities, attractive dividend, and potential upside from anticipated tariff resolutions for the food sector.

Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company was founded by Todd Foley, Patrick Baeuerle and Brian Goodman in August 2020 and is headquartered in Boston, MA.

Aktis Oncology Inc

Akoustis Technologies Inc

Akoustis Technologies Inc. is trending as it navigates bankruptcy proceedings and the sale of its assets, with the community largely expecting a wipeout for original shareholders. Compounding the conversation, the AKTS ticker is concurrently associated with Aktis Oncology, a newly IPO'd radiopharmaceutical company that has seen strong interest following a notable investment from Eli Lilly and a significant market debut.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evotec (NASDAQ:EVO) Sees Large Volume Increase - Should You Buy?

Evotec (NASDAQ:EVO) Sees Large Volume Increase - Time to Buy...

Evotec (NASDAQ:EVO) Shares Gap Up - Time to Buy?

Evotec (NASDAQ:EVO) Shares Gap Up - Still a Buy...

Evotec AG (NASDAQ:EVO) Receives Average Rating of "Hold" from Brokerages

Shares of Evotec AG (NASDAQ:EVO - Get Free Report) have received a consensus recommendation of "Hold" from the five brokerages that are currently covering the firm, Marketbeat.com reports. One...

Evotec (NASDAQ:EVO) Earns Buy Rating from Analysts at Berenberg Bank

Berenberg Bank initiated coverage on Evotec in a report on Tuesday. They set a "buy" rating for the company...

Evotec (NASDAQ:EVO) Shares Gap Down - Should You Sell?

Evotec (NASDAQ:EVO) Shares Gap Down - Time to Sell...

Evotec AG (NASDAQ:EVO) Short Interest Down 68.3% in December

Evotec AG (NASDAQ:EVO - Get Free Report) saw a significant decrease in short interest in December. As of December 31st, there was short interest totaling 251,399 shares, a decrease of 68.3% from the...

Evotec (NASDAQ:EVO) Shares Gap Up - What's Next...

Evotec (NASDAQ:EVO) Sees Strong Trading Volume - Time to Buy?

Evotec (NASDAQ:EVO) Sees Large Volume Increase - Still a Buy...

Wall Street Zen Upgrades Evotec (NASDAQ:EVO) to "Sell"

Wall Street Zen raised Evotec to a "sell" rating in a research note on Saturday...

Evotec (NASDAQ:EVO) Shares Gap Up - Here's What Happened

Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

EVO
Eaton Vance Ohio Municipal Income Trust

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest EVO News

EVOEaton Vance Ohio Municipal Income Trust